Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Categories: Washington Post

2 9/19/2018

One woman’s account of spinal cord stimulator skips realities of medical device safety in U.S.

6/27/2018

FDA approves new marijuana-derived drug, but was the evidence solid? Washington Post doesn’t say

4/17/2018

Immunotherapy prolongs survival, but at what cost? Washington Post needed more on treatment downsides

1/31/2018

Washington Post story on hyperbaric therapy for head injuries notes uncertain benefit–but not potential harms

12/12/2017

Gene therapy and hemophilia: Washington Post wisely tells readers ‘the study has some limitations’

11/14/2017

‘Regular painkillers work as well as opioids for fractures,’ but is this new information?

10/24/2017

Washington Post wisely quantifies severe side effects and deaths from CAR-T cell therapy

8/31/2017

Washington Post’s otherwise well-reported story on ecstasy for PTSD skirts evidence discussion

7/18/2017

Washington Post wisely notes that CAR T-cell therapy may cost at least $300,000

7/6/2017

Washington Post deftly examines lack of evidence for a fuzzy area of psychiatry: animal therapy